Who Says “No” to Participating in Stroke Clinical Trials and Why: An Observational Study From the Vancouver Stroke Program

Trials - United Kingdom
doi 10.1186/s13063-019-3434-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Vitamin B in Stroke Prevention: A Journey From Observational Studies to Clinical Trials and Critique of the VITAmins TO Prevent Stroke (VITATOPS)

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2011English

Randomized Clinical Stroke Trials in 2008

American Medical Journal
2010English

Targeting Neuroprotection Clinical Trials to Ischemic Stroke Patients With Potential to Benefit From Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

The Experiences of an Acute Stroke Unit--Implications for Multicentre Acute Stroke Trials.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1993English

Time to Publication for Publicly Funded Clinical Trials in Australia: An Observational Study

BMJ Open
Medicine
2017English

Neuroprotection for Acute Stroke : Making Clinical Trials Work

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1999English

Hospitals Struggle to Cope With Stroke Care, Says Royal College

BMJ
2002English

New Interventional Stroke Trials

Clinical Neuroradiology
Nuclear MedicineRadiologyImagingNeurology
2019English

Predicting Disability After Ischemic Stroke Based on Comorbidity Index and Stroke Severity—From the Virtual International Stroke Trials Archive-Acute Collaboration

Frontiers in Neurology
Neurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy